Manning & Napier Group, LLC Merck & Co., Inc. Transaction History

Manning & Napier Group, LLC

$8.76 Billion
Q1 2024

A detailed history of Manning & Napier Group, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Manning & Napier Group, LLC holds 433,356 shares of MRK stock, worth $53.6 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

433,356

Previous 477,808 9.3%

Holding current value

$53.6 Million

Previous $52.1 Million 9.77%

% of portfolio

0.65%

Previous 0.62%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	SELL	$113.24 - $131.95 $5.03 Million - $5.87 Million	-44,452 Reduced 9.3%	433,356 $57.2 Million
Q4 2023 Jan 19, 2024	SELL	$100.18 - $109.02 $6.89 Million - $7.49 Million	-68,741 Reduced 12.58%	477,808 $52.1 Million
Q3 2023 Oct 20, 2023	SELL	$102.95 - $114.33 $2.01 Million - $2.23 Million	-19,496 Reduced 3.44%	546,549 $56.3 Million
Q2 2023 Jul 26, 2023	BUY	$108.61 - $118.38 $5.02 Million - $5.47 Million	46,220 Added 8.89%	566,045 $65.3 Million
Q1 2023 Apr 17, 2023	SELL	$102.94 - $114.86 $268,879 - $300,014	-2,612 Reduced 0.5%	519,825 $55.3 Million

Q4 2022 Jan 26, 2023	SELL	$87.44 - $112.11 $1.15 Million - $1.47 Million	-13,125 Reduced 2.45%	522,437 $0
Q3 2022 Oct 18, 2022	SELL	$84.53 - $94.96 $835,579 - $938,679	-9,885 Reduced 1.81%	535,562 $46.1 Million
Q2 2022 Jul 12, 2022	SELL	$83.49 - $94.64 $9.89 Million - $11.2 Million	-118,484 Reduced 17.85%	545,447 $49.7 Million
Q1 2022 Apr 19, 2022	SELL	$73.51 - $82.4 $2.52 Million - $2.82 Million	-34,260 Reduced 4.91%	663,931 $54.5 Million
Q4 2021 Jan 27, 2022	SELL	$72.28 - $90.54 $2.15 Million - $2.69 Million	-29,736 Reduced 4.09%	698,191 $53.5 Million
Q3 2021 Oct 14, 2021	SELL	$71.68 - $78.83 $257,617 - $283,315	-3,594 Reduced 0.49%	727,927 $54.7 Million
Q2 2021 Jul 19, 2021	BUY	$70.31 - $77.77 $5.71 Million - $6.31 Million	81,200 Added 12.49%	731,521 $56.9 Million
Q1 2021 Apr 28, 2021	BUY	$68.86 - $81.11 $777,222 - $915,488	11,287 Added 1.77%	650,321 $50.1 Million
Q4 2020 Jan 20, 2021	SELL	$71.77 - $79.65 $1.48 Million - $1.64 Million	-20,613 Reduced 3.12%	639,034 $52.3 Million
Q3 2020 Oct 29, 2020	SELL	$73.18 - $82.95 $9.71 Million - $11 Million	-132,684 Reduced 16.75%	659,647 $54.7 Million
Q2 2020 Jul 10, 2020	BUY	$70.42 - $80.13 $302,453 - $344,158	4,295 Added 0.55%	792,331 $61.3 Million
Q1 2020 Apr 13, 2020	SELL	$63.36 - $87.82 $23.6 Million - $32.7 Million	-371,803 Reduced 32.06%	788,036 $60.6 Million
Q4 2019 Jan 10, 2020	BUY	$77.58 - $87.54 $3.92 Million - $4.42 Million	50,499 Added 4.55%	1,159,839 $105 Million
Q3 2019 Oct 10, 2019	SELL	$76.08 - $82.93 $36.2 Million - $39.5 Million	-475,785 Reduced 30.02%	1,109,340 $93.4 Million
Q2 2019 Jul 24, 2019	SELL	$69.84 - $81.59 $684,012 - $799,092	-9,794 Reduced 0.61%	1,585,125 $133 Million
Q1 2019 Apr 10, 2019	SELL	$69.58 - $79.36 $4.49 Million - $5.12 Million	-64,489 Reduced 3.89%	1,594,919 $133 Million
Q4 2018 Jan 24, 2019	SELL	$65.24 - $75.71 $6.81 Million - $7.9 Million	-104,333 Reduced 5.92%	1,659,408 $127 Million
Q3 2018 Oct 10, 2018	SELL	$57.69 - $67.84 $2.99 Million - $3.52 Million	-51,817 Reduced 2.85%	1,763,741 $125 Million
Q2 2018 Jul 13, 2018	SELL	$50.83 - $59.72 $5.28 Million - $6.2 Million	-103,849 Reduced 5.41%	1,815,558 $110 Million
Q1 2018 May 01, 2018	BUY	$50.96 - $59.23 $75.2 Million - $87.4 Million	1,475,333 Added 332.23%	1,919,407 $105 Million
Q4 2017 Feb 05, 2018	BUY	$51.62 - $61.64 $22.9 Million - $27.4 Million	444,074	444,074 $25 Million

Others Institutions Holding MRK

# of Institutions

3,766

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $314B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manning & Napier Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manning & Napier Group, LLC with notifications on news.

Account

Manning & Napier Group, LLC Merck & Co., Inc. Transaction History